A new-generation drug-coated balloon outperformed an evrolimus-eluting stent for the treatment of small vessel CAD lesions.
Researchers tried to determine whether natural or surgical premature menopause was associated with an elevated risk of clonal hematopoiesis of indeterminate potential with or without incident CAD events.
A novel tool in which clinical risk factors and coronary artery calcium score are added to standard pre-test probability modeling was found to improve risk prediction in suspected obstructive coronary artery disease.
The presence of calcified coronary atherosclerotic plaque morphology was found to predict all-cause and cardiovascular mortality among patients with coronary artery disease.
Daily colchicine treatment may reduce the risk for cardiovascular events in patients with chronic coronary disease.
Treatment of patients with left main coronary artery disease using percutaneous coronary intervention was associated with worse long-term outcomes compared with the use of coronary artery bypass grafting surgery.
Vasodilator stress, rest myocardial perfusion CMR, and LGE imaging were found to have high diagnostic accuracy for coronary artery disease.
Paclitaxel drug-coated balloon-only angioplasty was not found to be associated with late mortality within 5 years compared with nonpaclitaxel second-generation drug-eluting stents in patients with de novo coronary artery disease.
Coronary artery calcium (CAC) risk score is a better predictor of coronary heart disease (CHD) than stroke.
ACC releases recommendations regarding the use of coronary CTA as an initial tool for the diagnosis of stable coronary artery disease.